Medisys Technologies Reports on Patent Status of Blood Collection Safety Device.Business Editors/Health & Medical Writers BEDMINSTER, N.J.--(BW HealthWire)--Feb. 21, 2001 Medisys Technologies, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : SCEP SCEP Student Career Experience Program SCEP Simple Certificate Enrollment Protocol (Cisco) SCEP Syndicat Canadien des Communications, de l'Énergie et du Papier (Communications, Energy and Paperworkers Union) ) reported today that the U.S. Patent Office has allowed several claims in the Company's application for a patent protecting its proprietary VacuSaf(TM) veinous Vein´ous a. 1. Marked with veins; veined; veiny. The excellent old gentleman's nails are long and leaden, and his hands lean and veinous. - Dickens. blood collection safety device. Blood collection devices are used most often by phlebotomists and laboratory technicians to collect samples of blood from patients for diagnostic procedures. Medisys expects at least one patent to be issued within the year for this safety-engineered product. While the Company believes this patent will provide adequate protection for the device, Medisys is also pursuing additional claims. Medisys has produced working model prototypes for VacuSaf(TM) and has entered the pre-marketing stage for the device. VacuSaf(TM), an adaptation of the safety needle technology incorporated in the Company's patented hypodermic hypodermic /hy·po·der·mic/ (-der´mik) applied or administered beneath the skin. hy·po·der·mic adj. 1. Of or relating to the layer just beneath the epidermis. 2. safety syringe, is designed to cover and protect the sharp of a blood collection needle while it is still in the patient's vein. It protects the healthcare worker and waste handlers against dirty needlesticks and substantially reduces the patient's risk of accidental vein An imprecise term that refers generally to a continuous body of a mineral or mineralized rock filling a seam other than the principal vein that led to the discovery of the mining claim or location. Cross-references Mine and Mineral Law. injury. VacuSaf(TM) addresses the criteria of the safety sharps compliance directives established by the Occupational Safety and Health Administration Occupational Safety and Health Administration (OSHA), U.S. agency established (1970) in the Dept. of Labor (see Labor, United States Department of) to develop and enforce regulations for the safety and health of workers in businesses that are engaged in interstate (OSHA OSHA n. Occupational Safety and Health Administration, a branch of the US Department of Labor responsible for establishing and enforcing safety and health standards in the workplace. ). Its simple design requires little or no training for the user. "While focused on launching our patented proprietary CoverTip(TM) safety syringe, we have been dedicating a portion of our resources towards commercializing our other portfolio products," commented Kerry Frey, President and COO of Medisys. "We are very pleased with our progress in obtaining the necessary patent protection of our proprietary VacuSaf(TM) devices as we prepare for its market launch," he said. "On a dollar basis, VacuSaf(TM) is an ideal companion product for CoverTip(TM), with similar market potential." It is estimated that there are 800 million medical procedures conducted annually to collect blood specimens. About Medisys Technologies Medisys Technologies, Inc. is a diversified medical company that develops and markets patented products for improving safety and patient care. Spurred by recent federal regulations and state safety legislation, Medisys is currently concentrating on commercializing its portfolio of patented needle safety technology. The Company has 19 patents for new safety designs, including capillary blood testing and tissue excision cutting needles, and has been granted 510(k) clearance by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. to market its CoverTip(TM) hypodermic safety syringe. For more information about Medisys Technology and its proprietary suite of needle safety technologies, please contact Shayne Payne, Juan Dominguez or Dian Griesel, Ph.D. at the Investor Relations Investor relations The process by which the corporation communicates with its investors. Group: 212-736-2650, or visit us on the web at www.medisystech.com. Safe Harbor statement under the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: Except for historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including but not limited to economic, competitive, governmental and technological factors affecting the Company's operations, markets, products and prices and other factors discussed in the Company's various filings with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion